【结 构 式】 |
【药物名称】Sitaxsentan sodium, TBC-11251, Thelin 【化学名称】N-(4-Chloro-3-methylisoxazol-5-yl)-2-[2-(6-methyl-1,3-benzodioxol-5-yl)acetyl]thiophene-3-sulfonamide sodium salt 【CA登记号】210421-74-2, 184036-34-8 (free acid), 215501-46-5 (phosphate (1:1) salt) 【 分 子 式 】C18H14ClN2NaO6S2 【 分 子 量 】476.89288 |
【开发单位】Encysive Pharmaceuticals (Originator), LG Chem (Licensee) 【药理作用】CARDIOVASCULAR DRUGS, Heart Failure Therapy, Hypertension, Treatment of, Pulmonary Hypertension, Treatment of, Endothelin ETA Receptor Antagonists |
合成路线1
The condensation of 3-(chlorosulfonyl)thiophene-2-carboxylic acid methyl ester (I) with 4-chloro-3-methylisoxazol-5-amine by means of NaH in THF gives the corresponding sulfonamide (III), which is hydrolyzed with NaOH in methanol to yield the expected carboxylic acid (IV). The reaction of (IV) with N,O-dimethylhydroxylamine and carbonyldiimidazole (CDI) in THF affords the corresponding amide (V), which is finally condensed with the Grignard reagent 6-methyl-1,3-benzodioxol-5-ylmethyl magnesium chloride (VI) in THF. The intermediate Grignard reagent (VI) is obtained by chloromethylation of 5-methyl-1,3-benzodioxole (VII) with formaldehyde and HCl, giving 5-(chloromethyl)-6-methyl-1,3-benzodioxole (VIII), followed by reaction of this compound with Mg in THF.
【1】 Okun, I.; Keller, K.M.; Brock, T.; Kogan, T.P.; Stavros, F.; Chan, M.F.; Mong, S.; Raju, B.; Dixon, R.A.F.; Wu, C.; Discovery of TBC11251, a potent, long acting, orally active endothelin receptor-A selective antagonist. J Med Chem 1997, 40, 11, 1690-97. |
【2】 Leeson, P.A.; Castañer, J.; Graul, A.; Sitaxsentan Sodium. Drugs Fut 2000, 25, 2, 159. |
【3】 Chan, M.F.; Raju, B.G.; Kois, A.; Verner, E.J.; Wu, C.; Castillo, R.S.; Yalamoori, V.; Balaji, V.N. (Texas Biotechnology Corp.); Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivs. thereof that modulate the activity of endothelin. EP 0819125; JP 1999507015; WO 9631492 . |
【4】 Blok, N.; Keller, K.; Wu, C.; Kogan, T.; Woodard, P. (Texas Biotechnology Corp.); Sulfonamides for treatment of endothelin-mediated disorders. EP 0980369; US 5783705; WO 9849162 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 17836 | Methyl 3-(chlorosulfonyl)-2-thiophenecarboxylate; Methyl-3-chlorosulfonylthiophene-2-carboxylate | C6H5ClO4S2 | 详情 | 详情 | |
(II) | 17835 | 4-chloro-3-methyl-5-isoxazolamine; 4-chloro-3-methyl-5-isoxazolylamine | C4H5ClN2O | 详情 | 详情 | |
(III) | 17837 | methyl 3-[[(4-chloro-3-methyl-5-isoxazolyl)amino]sulfonyl]-2-thiophenecarboxylate | C10H9ClN2O5S2 | 详情 | 详情 | |
(IV) | 17838 | 3-[[(4-chloro-3-methyl-5-isoxazolyl)amino]sulfonyl]-2-thiophenecarboxylic acid | C9H7ClN2O5S2 | 详情 | 详情 | |
(V) | 32875 | 3-[[(4-chloro-3-methyl-5-isoxazolyl)amino]sulfonyl]-N-methoxy-N-methyl-2-thiophenecarboxamide | C11H12ClN3O5S2 | 详情 | 详情 | |
(VI) | 32876 | chloro[(6-methyl-1,3-benzodioxol-5-yl)methyl]magnesium | C9H9ClMgO2 | 详情 | 详情 | |
(VII) | 32878 | 5-methyl-1,3-benzodioxole | 7145-99-5 | C8H8O2 | 详情 | 详情 |
(VIII) | 32877 | 5-(chloromethyl)-6-methyl-1,3-benzodioxole | C9H9ClO2 | 详情 | 详情 |